BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35673672)

  • 1. Molecular analyses of rosette-forming glioneuronal tumor of the midbrain tegmentum: A report of two cases and a review of the FGFR1 status in unusual tumor locations.
    Handa H; Shibahara I; Nakano Y; Inukai M; Sato S; Hide T; Hirato J; Yoshioka T; Ichimura K; Kumabe T
    Surg Neurol Int; 2022; 13():213. PubMed ID: 35673672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumours.
    Appay R; Bielle F; Sievers P; Barets D; Fina F; Boutonnat J; Adam C; Gauchotte G; Godfraind C; Lhermitte B; Maurage CA; Meyronet D; Mokhtari K; Rousseau A; Tauziède-Espariat A; Tortel MC; Uro-Coste E; Burel-Vandenbos F; Chotard G; Pesce F; Varlet P; Colin C; Figarella-Branger D
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12813. PubMed ID: 35293634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapy.
    Halfpenny A; Ferris SP; Grafe M; Woltjer R; Selden N; Nazemi K; Perry A; Solomon DA; Gultekin SH; Moore S; Olson S; Lawce H; Lucas L; Corless CL; Wood MD
    Neuropathology; 2019 Oct; 39(5):389-393. PubMed ID: 31435988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle.
    Gessi M; Moneim YA; Hammes J; Goschzik T; Scholz M; Denkhaus D; Waha A; Pietsch T
    J Neuropathol Exp Neurol; 2014 Jun; 73(6):580-4. PubMed ID: 24806303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.
    Sievers P; Appay R; Schrimpf D; Stichel D; Reuss DE; Wefers AK; Reinhardt A; Coras R; Ruf VC; Schmid S; de Stricker K; Boldt HB; Kristensen BW; Petersen JK; Ulhøi BP; Gardberg M; Aronica E; Hasselblatt M; Brück W; Bielle F; Mokhtari K; Lhermitte B; Wick W; Herold-Mende C; Hänggi D; Brandner S; Giangaspero F; Capper D; Rushing E; Wesseling P; Pfister SM; Figarella-Branger D; von Deimling A; Sahm F; Jones DTW
    Acta Neuropathol; 2019 Sep; 138(3):497-504. PubMed ID: 31250151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
    Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
    Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosette-Forming Glioneuronal Tumor Originating From the Spinal Cord: Report of 2 Cases and Literature Review.
    Duan L; Zhang Y; Fu W; Geng S
    World Neurosurg; 2017 Feb; 98():875.e1-875.e7. PubMed ID: 27915062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosette-forming Glioneuronal Tumor: A Rare Posterior Fossa Tumor in an Adolescent.
    Bera G; Das A; Chatterjee S; Chatterjee U
    J Pediatr Neurosci; 2017; 12(2):168-171. PubMed ID: 28904578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological analysis of rosette-forming glioneuronal tumors.
    Liu J; Lin F; Sun Y; Liu X
    Diagn Pathol; 2024 Feb; 19(1):39. PubMed ID: 38388383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intractable epilepsy due to a rosette-forming glioneuronal tumor with a dysembryoplastic neuroepithelial background.
    Sumitomo N; Ishiyama A; Shibuya M; Nakagawa E; Kaneko Y; Takahashi A; Otsuki T; Kakita A; Saito Y; Sato N; Sugai K; Sasaki M
    Neuropathology; 2018 Jun; 38(3):300-304. PubMed ID: 29250844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H3 K27M mutation in rosette-forming glioneuronal tumors: a potential diagnostic pitfall.
    Marastoni E; Ammendola S; Rossi S; Giovannoni I; Broggi G; Masotto B; Feletti A; Barresi V
    Virchows Arch; 2024 Jan; ():. PubMed ID: 38233563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive genetic characterization of rosette-forming glioneuronal tumors: independent component analysis by tissue microdissection.
    Kitamura Y; Komori T; Shibuya M; Ohara K; Saito Y; Hayashi S; Sasaki A; Nakagawa E; Tomio R; Kakita A; Nakatsukasa M; Yoshida K; Sasaki H
    Brain Pathol; 2018 Jan; 28(1):87-93. PubMed ID: 27893178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA mutation in a mixed dysembryoplastic neuroepithelial tumor and rosette forming glioneuronal tumor, a case report and literature review.
    Eye PG; Davidson L; Malafronte PJ; Cantrell S; Theeler BJ
    J Neurol Sci; 2017 Feb; 373():280-284. PubMed ID: 28131206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rosette-forming glioneuronal tumor mimicked cerebral cysticercosis: a case report.
    Zhu D; Cheng A; Benons NTL; Chu S
    Neurol Sci; 2021 Oct; 42(10):4301-4308. PubMed ID: 34018072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Microenvironment and Lineage Tracing Help to Decipher Rosette-Forming Glioneuronal Tumors: A Multi-Omics Analysis.
    Lerond J; Morisse MC; Letourneur Q; Gimonnet C; Navarro S; Gaspar C; Idbaih A; Bielle F
    J Neuropathol Exp Neurol; 2022 Oct; 81(11):873-884. PubMed ID: 35984315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An individual patient data meta-analysis on characteristics and outcome of patients with papillary glioneuronal tumor, rosette glioneuronal tumor with neuropil-like islands and rosette forming glioneuronal tumor of the fourth ventricle.
    Schlamann A; von Bueren AO; Hagel C; Zwiener I; Seidel C; Kortmann RD; Müller K
    PLoS One; 2014; 9(7):e101211. PubMed ID: 24991807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors.
    Engelhardt S; Behling F; Beschorner R; Eckert F; Kohlhof P; Tatagiba M; Tabatabai G; Schuhmann MU; Ebinger M; Schittenhelm J
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):857-866. PubMed ID: 35018490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging features of rosette-forming glioneuronal tumours (RGNTs): A Series of seven cases.
    Medhi G; Prasad C; Saini J; Pendharkar H; Bhat MD; Pandey P; Muthane Y
    Eur Radiol; 2016 Jan; 26(1):262-70. PubMed ID: 26017735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of a rosette-forming glioneuronal tumor with clinicopathological features of a dysembryoplastic neuroepithelial tumor and fibroblast growth factor receptor 1 internal tandem duplication.
    Uchiyama T; Gomi A; Nobusawa S; Fukushima N; Matsubara D; Kawai K
    Brain Tumor Pathol; 2021 Jul; 38(3):250-256. PubMed ID: 33837479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusely invasive supratentorial rosette-forming glioneuronal tumor: illustrative case.
    Owusu-Adjei B; Mietus CJ; Lim JC; Lambert W; Daci R; Cachia D; Smith TW; Amenta PS
    J Neurosurg Case Lessons; 2023 Oct; 6(16):. PubMed ID: 37870758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.